Treating Tinnitus: A potential drug
What is tinnitus? It is a debilitating disorder where people suffer from
a chronic "phantom hearing sensation" i.e. perception of sound in the
absence of any acoustic stimuli. It is often perceived as hissing or ringing sound
in the ears.
Who is at risk? Tinnitus could happen to anyone among us. Even
listening to music at high volume for several hours daily is a known cause.
Its
prevalence ranges up to 15% in teens and adults. There is an acute increase in
its incidence among elderly, workers in noisy environment, or war veterans. Thus,
this study assumes great significance.
How does tinnitus progress? The exact changes that lead to its
development are still being debated. However, initial abnormal activity in the
auditory pathways has been described in most patients. It is also known that
trauma to cochlea, an inner ear structure responsible for hearing, can increase
the spontaneous activity in central auditory structures located downstream,
like inferior colliculus. This central hyperactivity has been suggested as a
possible neural basis for tinnitus. This work investigates this hypothesis as a
possible mechanism of tinnitus using guinea pigs.
Why use animals? Animals are used to understand the mechanisms
underlying a disorder, as well as to develop objective ways of measuring it,
and finally evaluate the therapeutic efficacy of any potential drug.
Why choose guinea pigs? Guinea pigs are effective in
tinnitus research as it is easy to dissect their ears. Further, they can be
induced with tinnitus by exposing them to continuous loud tone for hours while under
anaesthesia. Most importantly, they exhibit 'preyer reflex' where they cock
their (external) pinnae in response to startling sounds.
How do we know whether an animal is experiencing tinnitus? Since
tinnitus causes abnormal hearing perception, it is imperative to employ a behavioural
paradigm that enables us to observe the animal and infer its presence. Here the
preyer reflex of guinea pigs is exploited for this purpose.
Prepulse inhibition (PPI) is a
phenomenon where the preyer reflex is inhibited if a milder pre-stimulus is
presented immediately prior to the stronger startle stimulus. This is used to
check for normal hearing.
To check for tinnitus, instead of a
pre-stimulus a gap is presented in the background noise. If the noise resembled
the phantom sound experienced during tinnitus, then animals experiencing tinnitus
will fail to detect this gap, possibly due to a 'filling-in'. Thus, a failure
to inhibit the startle response confirms existence of tinnitus in an animal that
otherwise exhibits PPI.
How close is the guinea pig model of tinnitus? Previously
it has been shown using guinea pigs that after a cochlear trauma, hyperactivity
in central auditory regions is dependent on stimuli from peripheral auditory
structures for certain duration. In later stages, this hyperactivity is generated
intrinsically within those central structures without any need for peripheral stimulation.
These signs are very similar to those seen in humans. This motivates this study
to employ guinea pigs to investigate the effect of the drug furosemide on
tinnitus.
For the first time, a study (see reference [1]) provides direct evidence that a drug that reduces spontaneous activity in auditory nerve can relieve tinnitus.
How does furosemide act? The results presented in this study
suggest that an acute administration of furosemide in guinea pigs minimized
spontaneous activity in primary auditory areas. This reduced the central
hyperactivity that developed post trauma resulting in a decrease in the signs
of tinnitus in all animals tested. Importantly, it does not exert its influence
on either startle circuitry or the hearing sensitivity. Thus, this study
provides a mechanism for effect of furosemide as well as strengthens the central
hyperactivity hypothesis.
How good is furosemide as a cure for tinnitus? There are
many points to consider before coming to a conclusion. First, the dose of
furosemide tested in animals was much higher than the typical dose level used
in humans. Since lower doses are suitable for humans, further investigation is
required to ascertain its efficacy at lower concentration. Secondly, since this
study used a single dose of furosemide, further investigation is needed to check
whether the effect is long lasting or requires a repeated administration. Finally,
all animals tested were in the first stage of tinnitus. Thus, it is likely that
tinnitus becomes resistant to furosemide in the later stages but this needs to
be confirmed.
Summary: Furosemide is a promising drug to treat early stages of tinnitus
in humans, however many aspects of this drug still needs further investigation.
[1] Mulders, Wilhelmina HAM, Kristin M. Barry, and Donald Robertson. "Effects of Furosemide on Cochlear Neural Activity, Central Hyperactivity and Behavioural Tinnitus after Cochlear Trauma in Guinea Pig." PloS one 9.5 (2014): e97948.
[1] Mulders, Wilhelmina HAM, Kristin M. Barry, and Donald Robertson. "Effects of Furosemide on Cochlear Neural Activity, Central Hyperactivity and Behavioural Tinnitus after Cochlear Trauma in Guinea Pig." PloS one 9.5 (2014): e97948.
Comments
Post a Comment